News
€250,000 Investment from T3 GSYF to Nanomik Biotechnology!
As T3 Venture Capital Investment Fund (T3 GSYF), we have made a €250,000 investment in Nanomik Biotechnology, which develops natural preservation solutions for the agriculture and food sectors.
Having successfully completed its pre-Series A bridge investment round, Nanomik raised a total of €1 million in this round. The investment will be used to accelerate the company’s growth in the US, Türkiye, and EMEA (Europe, Middle East, and Africa) markets, establish global sales channels, and increase its R&D capacity.
Founded in Istanbul in 2015, Nanomik develops biological preservation solutions as alternatives to chemical and synthetic substances used in the agriculture, food, and construction industries. The company’s patented microencapsulation technology enhances the stability and effectiveness of natural active ingredients, enabling the delivery of sustainable, residue-free, and environmentally friendly products.
With field trials conducted in eight different countries over the past two years, Nanomik’s solutions stand out with their compliance with biocide regulations in the US and Europe. With this investment, the company aims to accelerate its transition from pilot applications to full commercialization.
As T3 GSYF, we invest in technology startups operating in fields such as artificial intelligence, biotechnology, mobility, advanced electronic systems, software, and robotics. Through our investments, we not only provide financial support but also contribute to the scale-up of startups by offering technical knowledge, strategic guidance, and collaboration opportunities.
We continue to support the growth of technology-focused startups and invest with the vision of building a sustainable future.